Updating results

55 results for IBS

Sort: Relevance | Date

Irritable bowel syndrome

All NICE products on Irritable bowel syndrome. Includes any guidance, advice, NICE Pathways and quality standards.

Irritable bowel syndrome in adults: diagnosis and management (CG61)

This guideline covers diagnosing and managing irritable bowel syndrome (IBS) in people aged 18 and over. It details how to accurately diagnose IBS, and aims to improve the quality of life for adults with IBS by promoting effective management using dietary and lifestyle advice, pharmacological therapy and referral for psychological interventions.

Clinical guideline Published February 2008 Last updated April 2017

Irritable bowel syndrome in adults

Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart

NICE Pathway Published October 2012 Last updated May 2019

Eluxadoline for treating irritable bowel syndrome with diarrhoea (TA471)

Evidence-based recommendations on eluxadoline (Truberzi) for treating irritable bowel syndrome (IBS) with diarrhoea in adults

Technology appraisal guidance Published August 2017

SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

Evidence-based recommendations on SeHCAT (tauroselcholic [75 selenium] acid) for investigating diarrhoea due to bile acid malabsorption (BAM)

Diagnostics guidance Published November 2012

Ovarian cancer: recognition and initial management (CG122)

This guideline covers detecting, diagnosing and treating women (18 years and older) who have, or are suspected of having, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer or borderline ovarian cancer. It aims to enable earlier detection of ovarian cancer and improve initial treatment.

Clinical guideline Published April 2011

Irritable bowel syndrome in adults (QS114)

This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.

Quality standard Published February 2016

Crohn's disease

Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart

NICE Pathway Published October 2012 Last updated August 2019

Irritable bowel syndrome with constipation in adults: linaclotide (ESNM16)

Summary of the evidence on linaclotide for irritable bowel syndrome (IBS) with constipation in adults to inform local NHS planning and decision-making

Evidence summary Published April 2013

Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

Evidence-based recommendations on faecal calprotectin diagnostic tests for inflammatory diseases of the bowel

Diagnostics guidance Published October 2013

Improving diagnosis and quality of care for people with IBS across Somerset

NICE's IBS guidance ( NICE guideline CG61 ) within Somerset. They examined current arrangements for diagnosis, investigation and...

QP Case Study Published July 2016

Ulcerative colitis

Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart

NICE Pathway Published June 2013 Last updated June 2019

Suspected cancer: recognition and referral (NG12)

This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.

NICE guideline Published June 2015 Last updated July 2017

Laxatives (KTT1)

guideline on irritable bowel syndrome (IBS) recommends that laxatives should be considered for treating constipation in...

Key therapeutic topic Published January 2015

Coeliac disease: recognition, assessment and management (NG20)

This guideline covers the recognition, assessment and management of coeliac disease in children, young people and adults.

NICE guideline Published September 2015

Coeliac disease (QS134)

This quality standard covers recognising, assessing and managing coeliac disease in adults, young people and children. It describes high-quality care in priority areas for improvement.

Quality standard Published October 2016

Coeliac disease

Everything NICE has said on recognising, diagnosing and managing coeliac disease in an interactive flowchart

NICE Pathway Published October 2012 Last updated October 2017

Bile acid malabsorption: colesevelam (ESUOM22)

Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

Evidence summary Published October 2013

Faecal incontinence in adults: management (CG49)

This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.

Clinical guideline Published June 2007

Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

CG61/3 Question Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS? Any...

Research recommendation Published June 2015

Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related outcomes?

What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related...

Research recommendation Published June 2015

Herbal medicines:- Are Chinese and non-Chinese herbal medicines safe and effective as first-line therapy in the treatment of [Irritable bowel syndrome] (IBS), and which is the most effective and safe option?

safe and effective as first-line therapy in the treatment of [Irritable bowel syndrome] (IBS), and which is the most...

Research recommendation Published June 2015

Research is needed to establish the efficacy and tolerability of bile acid sequestrants among people with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

and tolerability of bile acid sequestrants among people with irritable bowel syndrome (IBS-D) or Crohn's disease without...

Research recommendation Published June 2015

Research is needed to establish the nature of bile acid malabsorption and whether bile acid malabsorption is a primary or secondary condition in people diagnosed with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

is a primary or secondary condition in people diagnosed with irritable bowel syndrome (IBS-D) or Crohn's disease without...

Research recommendation Published June 2015

Endorsement

Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.

Published August 2019 Last updated August 2019

Ovarian cancer (QS18)

This quality standard covers the recognition and initial management of ovarian cancer. It describes high-quality care in priority areas for improvement.

Quality standard Published May 2012

Ovarian cancer

Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

NICE Pathway Published February 2012 Last updated April 2019

Improving Access to Psychological Therapies (IAPT)

Improving Access to Psychological Therapies (IAPT) services provide evidence-based psychological therapies to people with anxiety disorders and depression.

Published August 2019 Last updated August 2019

Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013 (PMG17)

Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013

Published October 2013 Last updated October 2013

Shared learning awards previous winners and finalists

Flexible Healthcare Team: Empowering patients and GPs to manage irritable bowel syndrome Finalists Champs Public Health Collaborative:...

Published June 2019 Last updated June 2019

Research recommendations

management of [Irritable bowel syndrome] (IBS) symptoms, either as first-line therapies in primary care, or in the...

Published April 2016 Last updated April 2016

Prucalopride for the treatment of chronic constipation in women (TA211)

Evidence-based recommendations on prucalopride (Resolor) for treating chronic constipation in women

Technology appraisal guidance Published December 2010

Food allergy (QS118)

This quality standard covers diagnosing, assessing and managing food allergy in children and young people (under 19) and adults. It describes high-quality care in priority areas for improvement.

Quality standard Published March 2016

Inflammatory bowel disease (QS81)

This quality standard covers diagnosing and managing inflammatory bowel disease (Crohn’s disease and ulcerative colitis) in adults, young people and children. It describes high-quality care in priority areas for improvement.

Quality standard Published February 2015

Faecal incontinence in adults (QS54)

This quality standard covers managing faecal (bowel) incontinence in adults (aged 18 and over) in the community (at home and in care homes) and in all hospital departments. It includes assessment of bowel control problems, advice and support, and treatment options. It describes high-quality care in priority areas for improvement.

Quality standard Published February 2014

Naloxegol for treating opioid‑induced constipation (TA345)

Evidence-based recommendations on naloxegol (Moventig) for treating opioid-induced constipation that has had inadequate response to laxatives

Technology appraisal guidance Published July 2015

Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management (CG53)

This guideline covers diagnosing and managing chronic fatigue syndrome (CFS) which is also known as myalgic encephalomyelitis (ME) (or encephalopathy). It aims to improve the quality of life for people with CFS/ME by setting out the care and treatment options that should be available for them.

Clinical guideline Published August 2007

Constipation (opioid induced) - methylnaltrexone bromide [ID700]

In development [GID-TA10003] Expected publication date: TBC

Technology appraisal guidance In development

Constipation (opioid induced) - lubiprostone [ID646]

In development [GID-TAG367] Expected publication date: 01 October 2014

Technology appraisal guidance In development

Food allergy in under 19s

Everything NICE has said on diagnosing and assessing food allergy in children and young people in primary care and community settings in an interactive flowchart

NICE Pathway Published December 2011 Last updated October 2018

Block scoping reports

This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

Published July 2019 Last updated July 2019

Faecal incontinence

Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

NICE Pathway Published February 2013 Last updated June 2019

Integrated multiplex PCR tests for identifying gastrointestinal pathogens in people with suspected gastroenteritis (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B assay) (DG26)

Evidence-based recommendations on integrated multiplex polymerase chain tests for identifying gastrointestinal pathogens in suspected gastroenteritis

Diagnostics guidance Published January 2017

Being monitored and out of remit procedures

been published for 1259 / 1 Sacral Nerve Stimulation for Irritable Bowel Syndrome DIGESTIVE SYSTEM Not In Use 126 / 3 Prosthetic...

Published August 2019 Last updated August 2019

Supporting patients with gastrointestinal problems: better pathway, better outcomes

Victoria Hilton and her team, finalists of the NICE Shared Learning Awards, tell us about an improved care pathway to support better outcomes for patients with gastrointestinal problems

News Published May 2018 Last updated May 2018

£3 a day drug for irritable bowel syndrome gets NICE approval

The drug, Truberzi has been recommended for routine funding on the NHS to treat patients with irritable bowel syndrome and diarrhoea (IBS-D).

News Published July 2017 Last updated July 2017